Keppra vs. Briviact

• Are Keppra and Briviactthe Same Thing?
• What Are Possible Side Effects of Keppra?
• What Are Possible Side Effects of Briviact?
• What is Keppra?
• What is Briviact?
• What Drugs Interact with Keppra?
• What Drugs Interact with Briviact?
• How Should Keppra Be Taken?
• How Should BriviactBe Taken?

Keppra (levetiracetam) and Briviact (brivaracetam) are anti-epileptic drugs (AEDs) (anticonvulsants) used to treat types of seizures in people with epilepsy.

Common side effects of Keppra include:

• drowsiness,
• weakness,
• infection,
• loss of appetite,
• stuffy nose,
• tiredness, and
• dizziness.

Side effects of Keppra in children include

• sleepiness,
• accidental injury,
• hostility, nervousness, and
• weakness.

Common side effects of Briviact include:

• drowsiness,
• sedation,
• dizziness,
• fatigue,
• nausea,
• vomiting,
• loss of balance or coordination,
• irritability, and
• constipation

Antiepileptic drugs, including Briviact, may increase the risk of suicidal thoughts or behavior in patients taking these drugs. Tell your doctor immediately if this occurs.

Keppra (levetiracetam) is an anti-epileptic drug (AED) (antoconvulsant) often used in conjunction with other drugs to treat types of seizures in people with epilepsy.

Briviact (brivaracetam) is an antiepileptic drug (AED) indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.

Keppra may interact with alcohol.

Briviact may interact with rifampin, carbamazepine, and phenytoin.

Keppra (levetiracetam) is available in pills in the following dosages and colors: 250 mg (blue), 500 mg (yellow), 750 mg (orange), and 1,000 mg (white). Keppra (levetiracetam) is also available as a clear, colorless grape-flavored liquid at a concentration of 100 mg/mL. Drug interactions include phenytoin, valproate, oral contraceptives, digoxin, warfarin, and probenecid. Keppra (levetiracetam) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Keppra (levetiracetam) is excreted in breast milk. Women must talk to their doctors to decide whether to discontinue nursing or the drug.

The recommended starting dosage of Briviact is 50 mg twice daily. Based on individual patient tolerability and therapeutic response, the dosage of Briviact may be adjusted down to 25 mg twice daily (50 mg per day) or up to 100 mg twice daily (200 mg per day). Briviact may interact with rifampin, carbamazepine, and phenytoin. Tell your doctor all medications and supplements you use. Briviact is not recommended for use during pregnancy; it may harm a fetus. It is unknown if Briviact passes into breast milk. Consult your doctor before breastfeeding.